JP3431300007
JP3431300007
NXERA PHARMA CO LTD
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 29.615.000.000 | 28.835.000.000 | 2.7% |
| Cost of Revenue | 8.198.000.000 | 7.616.000.000 | 7.6% |
| Gross Profit | 21.418.000.000 | 21.219.000.000 | 0.9% |
| 29.880.000.000 | 26.642.000.000 | 12.2% | |
| Operating Income | -8.462.000.000 | -5.423.000.000 | 56.0% |
| Pretax Income | -14.950.000.000 | -4.662.000.000 | 220.7% |
| Net Income Common Stockholders | -12.530.000.000 | -4.838.000.000 | 159.0% |
| -- | -- | -- | |
| -- | -- | -- |